Targeting Mitochondrial MAVS Signaling in Deep-Senescent Hematopoietic Stem Cells Ameliorates Infection-Driven Immunosenescence
Aging and Disease · 2026
DOI: 10.14336/ad.2026.0944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging and Disease, 2026. Verfasst von Weinian Liao und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing, China.
Abstract (Originalsprache)
Acute viral infections cause immediate tissue damage and exert long-term detrimental effects on host immunity and hematopoiesis. However, the mechanisms by which infection drives hematopoietic stem cell (HSC) aging and accelerates immunosenescence remain poorly defined. Here, using a non-lethal influenza A virus (IAV) infection model, we demonstrate that middle-aged mice, rather than young mice, are uniquely susceptible to infection-driven immune deterioration. Infection superimposed on baseline physiological aging drives sustained chronic inflammation and accelerated immunosenescence in middle-aged mice. We identify an infection-induced deep senescence state of HSCs as a major contributor to systemic immunosenescence. This deep senescence state is characterized by p16 upregulation, elevated aging markers, increased my-HSC frequency, and mitochondrial dysfunction. Mechanistically, disrupted mitochondrial homeostasis triggers cytosolic mitochondrial RNA (mtRNA) accumulation and sustained MAVS pathway activation, forming a pathogenic feedforward loop that perpetuates HSC aging. Through high-throughput screening, we identify Bilobetin, a natural biflavonoid, as a potent mitochondria-targeted compound that restores mitochondrial fitness, dampens aberrant MAVS signaling, and ameliorates both HSC aging and systemic immunosenescence. Collectively, our findings establish a hematopoietic-immune senescence stratification model and delineate the molecular threshold separating physiological adaptation from pathological deterioration in infection-driven aging, identifying mitochondria-targeted interventions as a therapeutic strategy for mitigating infection-induced immuno-senescence.
Autor:innen und Institutionen
- National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing, China.
- Department of Hepatobiliary Surgery, Mianyang 404 Hospital, Mianyang, Sichuan, China.
Zitieren
APA
Liao, W., Zhang, Y., Wang, Y., Zhao, R., Xu, C., Wang, T., Xie, M., Zhang, Z., Zai, X., Wang, Z., Zhang, J., & Xu, J. (2026). Targeting Mitochondrial MAVS Signaling in Deep-Senescent Hematopoietic Stem Cells Ameliorates Infection-Driven Immunosenescence. Aging and Disease. https://doi.org/10.14336/ad.2026.0944
Vancouver
Liao W, Zhang Y, Wang Y, Zhao R, Xu C, Wang T, et al. Targeting Mitochondrial MAVS Signaling in Deep-Senescent Hematopoietic Stem Cells Ameliorates Infection-Driven Immunosenescence. Aging and Disease. 2026. doi:10.14336/ad.2026.0944
BibTeX
@article{Liao2026,
author = {Liao, Weinian and Zhang, Yue and Wang, Yetong and Zhao, Ruzhou and Xu, Cheng and Wang, Tianyue and Xie, Mingyang and Zhang, Zhang and Zai, Xiaodong and Wang, Zhongyi and Zhang, Jun and Xu, Junjie},
title = {Targeting Mitochondrial MAVS Signaling in Deep-Senescent Hematopoietic Stem Cells Ameliorates Infection-Driven Immunosenescence},
journal = {Aging and Disease},
year = {2026},
doi = {10.14336/ad.2026.0944}
}
EUVIMED